ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma Meeting Abstract
| Authors: | Liu, J.; Colombo, N.; Oza, A.; Frenel, J. S.; Corr, B.; Rubinstein, M.; Nevadunsky, N.; Lheureux, S.; Gaba, L.; Cortijo, L. G.; Salutari, V.; You, B.; de Giorgio-Miller, V.; Khatun, M.; Ghiorghiu, D.; Oaknin, A. |
| Abstract Title: | ADAGIO: A phase IIb, open-label, single-arm, multicenter study assessing the efficacy and safety of adavosertib (AZD1775) as treatment for recurrent or persistent uterine serous carcinoma |
| Meeting Title: | Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer (54th Annual Meeting) |
| Journal Title: | Gynecologic Oncology |
| Volume: | 176 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2023 Mar 25-28 |
| Meeting Location: | Tampa, FL |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2023-09-01 |
| Start Page: | S33 |
| End Page: | S35 |
| Language: | English |
| ACCESSION: | WOS:001079556100049 |
| DOI: | 10.1016/j.ygyno.2023.06.512 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 039 -- Source: Wos |
